Antibiotic with a novel penetrative mechanism.
Results presented at the 2019 AAGL Congress demonstrated a higher rate of UTI among younger patients with increased estimated blood loss (EBL) following the procedure.
Risk of postop urinary retention may vary depending on when devices are removed.
Uropathogens may not be the only bacteria shared between the vagina and bladder.
Results of a study by Canadian researchers suggest that exposure to low and medium doses of cranberry juice may have potential to reduce physician visits and costs for women who have a history of recurrent urinary tract infection (UTI).
Results of a Phase 3 randomized clinical trial (RCT) suggest that a combination carbapenem/beta-lactamase inhibitor may have potential in treatment of severe drug-resistant gram-negative urinary tract infections (UTI).
Results of a multinational trial show that a 5-day course of nitrofurantoin may produce better outcomes in women with uncomplicated lower urinary tract infection (UTI) than a single dose of fosfomycin.
A study from Belgium has found that women with typical symptoms of urinary tract infection (UTI) may still be infected with the uropathogen Escherichia coli despite a negative culture result.
In a Swiss comparative trial, diclofenac was found to be inferior to norfloxacin for treatment of urinary tract infection (UTI).
Findings from a recent study indicate that trimethoprim 200 mg BID for 3 or 7 days is the most effective antibiotic for uncomplicated urinary tract infection (UTI) when levels of local resistance to the drug are < 30%. However, when it is ≥ 35%, a single dose of fosfomycin 3g or nitrofurantoin 100 mg BID for 7 days is more cost-effective.